Przewaquinone A

Przewaquinone A

SCHEMBL16152272

CC1(C)CCCc2c1ccc1c2C(=O)C(=O)c2c(CO)coc2-1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 11/20 1.00
▸ TDO2 P48775 10/20 1.00
▸ MEN1 O00255 5/20 0.74
▸ ALDH1A1 P00352 5/20 0.74
▸ KMT2A Q03164 5/20 0.74
▸ HIF1A Q16665 4/20 0.74
▸ EPAS1 Q99814 4/20 0.74
▸ CES2 O00748 4/20 0.74
▸ HPGD P15428 4/20 0.74
▸ HSD17B10 Q99714 4/20 0.74
▸ EED O75530 3/20 0.74
▸ SUZ12 Q15022 3/20 0.74
▸ EZH2 Q15910 3/20 0.74
▸ KDM4E B2RXH2 3/20 0.74
▸ MAPT P10636 3/20 0.74
▸ RECQL P46063 3/20 0.74
▸ TDP1 Q9NUW8 3/20 0.74
▸ POLB P06746 2/20 0.74
▸ CES1 P23141 2/20 0.74
▸ PTPN6 P29350 2/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tanshinone Iia SCHEMBL2026738 0.85 EED (1.00) IDO1TDO2MEN1ALDH1A1KMT2A
SCHEMBL30017207 0.81 IDO1 (1.00) IDO1TDO2MEN1ALDH1A1KMT2A
Tanshinone Iib SCHEMBL11945767 0.78 EED (1.00) IDO1TDO2MEN1ALDH1A1KMT2A
Tanshinone Iib SCHEMBL14417728 0.78 EED (1.00) IDO1TDO2MEN1ALDH1A1KMT2A
SCHEMBL16023777 0.77 EED (0.84) IDO1TDO2MEN1ALDH1A1KMT2A
SCHEMBL29538928 0.77 EED (0.84) IDO1TDO2MEN1ALDH1A1KMT2A
SCHEMBL16152326 0.76 EED (0.78) IDO1TDO2MEN1ALDH1A1KMT2A
SCHEMBL14417696 0.76 EED (0.76) IDO1TDO2MEN1ALDH1A1KMT2A
SCHEMBL16152283 0.76 EED (0.76) IDO1TDO2MEN1ALDH1A1KMT2A
SCHEMBL25704333 0.73 EED (0.65) IDO1TDO2MEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119380826-B Chinese patent medicine network pharmacology analysis method and model construction method based on multiscale information entropy 首都医科大学附属北京朝阳医院 2025-04-08 — — CN disclosed
CN-119380826-A Chinese patent medicine network pharmacology analysis method and model construction method based on multiscale information entropy 首都医科大学附属北京朝阳医院 2025-01-28 — — CN disclosed
CN-117137923-A Application of salvianic acid A in preparing AMPK (open-end AMPK) agonist 广州医科大学附属第二医院 2023-12-01 — — CN disclosed
CN-112667922-B Novel coronavirus traditional Chinese medicine formula recommendation method and system based on collaborative filtering 山东大学 2022-06-28 — — CN disclosed
CN-114010745-A Traditional Chinese medicine composition for treating rheumatism bone disease and traumatic injury, preparation method and using method 徐创金 2022-02-08 — — CN disclosed
EP-2786990-B1 2-AMINATED METHYLENE OR 2-ESTERIFIED METHYLENE TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF HANGZHOU BENSHENG PHARMACEUTICAL CO LTD (CN) 2018-08-08 — — EP disclosed
US-9771343-B2 2-alkyl-or-aryl-substituted tanshinone derivatives, and preparation method and application thereof HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) 2017-09-26 — — US disclosed
US-9771343-B2 2-alkyl-or-aryl-substituted tanshinone derivatives, and preparation method and application thereof HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) 2017-09-26 — — US disclosed
US-9328083-B2 2-aminated methylene or 2-esterified methylene tanshinone derivatives, and preparation method and application thereof HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) 2016-05-03 — — US disclosed
US-9328083-B2 2-aminated methylene or 2-esterified methylene tanshinone derivatives, and preparation method and application thereof HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) 2016-05-03 — — US disclosed
US-20150126552-A1 2-AMINATED METHYLENE OR 2-ESTERIFIED METHYLENE TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) 2015-05-07 — — US disclosed
US-20150126552-A1 2-AMINATED METHYLENE OR 2-ESTERIFIED METHYLENE TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) 2015-05-07 — — US disclosed
US-20140336249-A1 2-ALKYL-OR-ARYL-SUBSTITUTED TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) 2014-11-13 — — US disclosed
US-20140336249-A1 2-ALKYL-OR-ARYL-SUBSTITUTED TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) 2014-11-13 — — US disclosed
EP-2786989-A1 2-ALKYL-OR-ARYL-SUBSTITUTED TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF Hangzhou Bensheng Pharmaceutical Co., Ltd. (CN) 2014-10-08 — — EP disclosed
EP-2786990-A1 2-AMINATED METHYLENE OR 2-ESTERIFIED METHYLENE TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF Hangzhou Bensheng Pharmaceutical Co., Ltd. (CN) 2014-10-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150126552-A1 2-AMINATED METHYLENE OR 2-ESTERIFIED METHYLENE TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF NQO1, NFE2L2, NOS2 IDO1 2094/4885TDO2 386/4885MEN1 977/4885
US-20140336249-A1 2-ALKYL-OR-ARYL-SUBSTITUTED TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF CYP2A7, TBXAS1, CYP2J2 IDO1 1716/4885TDO2 828/4885MEN1 2512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback